Benatar M (invited speaker). Phase II/III Randomized Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial ALS. Packard Center 9th Annual Meeting. Baltimore, MD, April 2009. [PubMed Link]
Recent Posts
- Landmark Study Identifies Novel Pre-Symptomatic Biomarkers and Accelerates Progress Towards ALS Prevention
- July 26, 2026: Miami Marlins Game
- Feature: UHealth’s Qalsody Clinic Provides Cutting-Edge Care for ALS Patients
- The New York Times Feature: In a Milestone for A.L.S., a Treatment Helps Some Patients Improve
- CReATe Author Series Ep. 18 – Dr. Michael Benatar on MMI as a prodromal stage of ALS
Recent Comments